T1	Participants 174 242	patients who are treated with this modality for pelvic malignancies.
T2	Participants 556 597	31 patients receiving pelvic radiotherapy
T3	Participants 1103 1178	Groups did not differ in age, gender, tumor site, or irradiation procedure.
T4	Participants 1606 1618	the subjects
T5	Participants 1681 1725	radiation-induced gastrointestinal injuries.
